BENGALURU (Reuters) - The U.S. Food and Drug Administration (FDA) has raised doubts about Strides Pharma Sciences Ltd's quality-control practices after finding adulteration and evidence of ...
Strides Pharma has obtained the Food and Drug Administration’s approval for two generics. Strides’ subsidiary, Strides Pharma Global, Singapore, has received approval from the FDA for Sodium Sulphate, ...
Strides Pharma share price falls over 3% on plans to spin off CDMO, gelatin biz into separate entity
Strides Pharma share price was down 5.5% from its 52-week high of ₹549.00 apiece hit on September 25.(Photo: Company Website) Strides Pharma Science share price declined over 3% in early trade on ...
Strides Pharma will spin off its CDMO and soft gelatin businesses into new entity Shares of Strides Pharma fell 3 percent to Rs 518 per share on September 26, after the company announced plans to spin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results